Mark S Leventhal, a director of ProPhase Labs, recently acquired 14,248 shares of the company. The buys took place at prices ranging from $1.48 to $1.55 per share, on dates ranging from November 27 to November 30, 2015. Leventhal now owns 881,980 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 30, 2015.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.56, inclusive.
These shares w
ere purchased in a single transaction at a price of $1.48.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017